The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: two for Product Development Awards (committee A and committee B), one for Challenge Awards, and one for Connect.
Committee members - Challenge Awards
| Name | Position | Organisation | Expertise |
|---|---|---|---|
| Professor Nick Lemoine (Chair) | Director | Barts Cancer Institute | Professor Lemoine is Director of R&D for Cancer at Barts Health NHS Trust and Medical Director of the NIHR Clinical Research Network. He is also a Director of the QMUL spin-out company VacV Therapeutics Ltd and has an interest in the development of oncolytic virotherapy and cancer vaccines. |
| Ms Joanna Smart (Deputy Chair) | Non Executive Chair | Oxford Cancer Biomarkers | Ms Smart is a life sciences business executive with over 15 years' experience. Ms Smart has experience in advising life sciences companies on licensing, corporate strategy, fundraising and M&A opportunities |
| Mrs Janet Champion | Public Committee Member | PPI Representative | PPI Representative |
| Mr Chris Chaney | Chief Executive | Chelsea and Westminster Hospitals NHS Foundation Trust | Mr Chaney leads the innovation programme at Chelsea and Westminster Hospital Foundation Trust, is a member of the Trust Board and CEO of Trust charity, CW+ |
| Associate professor Iain Hennessey | Clinical Director of Innovation | Alder Hay Children’s NHS Foundation Trust | Dr Hennessey is involved in paediatric surgery, surgical simulation and clinical innovation. |
| Professor Claire Hulme | Professor of Health Economics & Head of Department of Health & Community Sciences | Institute of Health Research, University of University of Exeter Medical School, Faculty of Health & Life Sciences, University of ExeterExeter | Professor Hulme is a health economist whose background lies in range of methodologies including economic evaluation, large data analysis and use of qualitative methods in health economics. |
| Mrs Ceila Ingham-Clark | Medical Director for Clinical Effectiveness | NHS England | Mrs Clark is a Medical Director for Professional Leadership and Clinical Effectiveness; previous Trust Medical Director and general surgeon. |
| Dr Zarnie Khadjesari | Senior Lecturer in Health Promotion | University of East Anglia | Dr Khadjesari is an implementation scientist and digital health researcher in the field of health promotion. She is experienced in both quantitative and qualitative research methods. |
| Dr David Kryl | Director of Insight for Wessex AHSN | Wessex Academic Health Science Network (AHSN) | Dr Kryl is responsible for the evaluation strategy of Wessex Academic Health Science Network, with expertise in implementation, research, evaluation, and impact assessment frameworks |
| Mr Stuart Mealing | Associate Director for Health Technology Assessment | York Health Economics Consortium Ltd | Mr Mealing has a range of experience in decision analytic modelling, statistical analysis of patient level data (from clinical trials to large real world evidence datasets), Preparation of health technology assessment submission dossiers |
| Professor Steve Morris | CEO | Ingram Networks Ltd | Professor Morris was co-founder of Creo Medical Plc and served as Chief Operating Officer for 10 years. During this time he was Lead Applicant and subsequently Chief Investigator for a number of NIHR-funded i4i and SBRI projects. He played a key role in the development of medical devices from concept to regulatory approval and first Human Use. He was awarded a Visiting Professorship by the Royal Academy of Engineering in 2020. |
| Ms Stella O'Brien | Public Committee Member | PPI Representative | PPI Representative |
| Mr Sebastian Orton | Partner, Corporate | Penningtons Manches Cooper LLP | Mr Orton is a corporate finance lawyer with specific expertise in equity capital markets and raising finance for companies in the life sciences sector |
| Professor Najib Rahman | Professor of Respiratory Medicine, Director Oxford Respiratory Trials Unit | University of Oxford | Professor Rahman has a broad range of expertise in clinical trials methodology, design, outcome and analysis. As well as expertise in, respiratory medicine including pleural disease, sleep apnoea, respiratory interventions, imaging, airways disease and lung cancer |
| Professor Amar Rangan | Professor of Orthopaedic Surgery | Universities of York and Oxford | Professor Rangan is a specialist shoulder & elbow surgeon. Experienced in clinical effectiveness and translational research |
| Professor Wendy Tindale | Director | Sheffield Teaching Hospitals; NIHR Devices for Dignity MIC | Professor Tindale is a Consultant Medical Physicist and is experienced in collaborative MedTech development and NHS implementation |